Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-24T10:36:51.127Z Has data issue: false hasContentIssue false

Varying Rates of Clostridium Difficile-Associated Diarrhea at Prevention Epicenter Hospitals

Published online by Cambridge University Press:  21 June 2016

SeJean Sohn
Affiliation:
Memorial Sloan-Kettering Cancer Center, New York, New York
Michael Climo
Affiliation:
Memorial Sloan-Kettering Cancer Center, New York, New York
Daniel Diekema
Affiliation:
University of Iowa Carver College of Medicine, Iowa City, Iowa
Victoria Fraser
Affiliation:
Washington University School of Medicine, St. Louis, Missouri
Loreen Herwaldt
Affiliation:
University of Iowa Carver College of Medicine, Iowa City, Iowa
Susan Marino
Affiliation:
Brigham & Women's Hospital, Boston, Massachusetts
Gary Noskin
Affiliation:
Northwestern University Medical Center, Chicago, Illinois
Trish Perl
Affiliation:
Johns Hopkins University, Baltimore, Maryland
Xiaoyan Song
Affiliation:
Johns Hopkins University, Baltimore, Maryland
Jerome Tokars
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
David Warren
Affiliation:
Washington University School of Medicine, St. Louis, Missouri
Edward Wong
Affiliation:
Hunter Holmes McGuire Veteran Affairs Medical Center, Richmond, Virginia
Deborah S. Yokoe
Affiliation:
Brigham & Women's Hospital, Boston, Massachusetts
Theresa Zembower
Affiliation:
Northwestern University Medical Center, Chicago, Illinois
Kent A. Sepkowitz*
Affiliation:
Memorial Sloan-Kettering Cancer Center, New York, New York
*
Director, Infection Control, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021., sepkowik@mskcc.org

Abstract

Background:

Clostridium difficile-associated diarrhea (CDAD) causes substantial healthcare-associated morbidity. Unlike other common healthcare-associated pathogens, little comparative information is available about CDAD rates in hospitalized patients.

Objectives:

To determine CDAD rates per 10,000 patient-days and per 1,000 hospital admissions at 7 geographically diverse tertiary-care centers from 2000 to 2003, and to survey participating centers on methods of CDAD surveillance and case definition.

Methods:

Each center provided specific information for the study period, including case numbers, patient-days, and hospital characteristics. Case definitions and laboratory diagnoses of healthcare-associated CDAD were determined by each institution. Within institutions, case definitions remained consistent during the study period.

Results:

Overall, mean annual case rates of CDAD were 12.1 per 10,000 patient-days (range, 3.1 to 25.1) and 7.4 per 1,000 hospital admissions (range, 3.1 to 13.1). No significant increases were observed in CDAD case rates during the 4-year interval, either at individual centers or in the Prevention Epicenter hospitals as a whole. Prevention Epicenter hospitals differed in their CDAD case definitions. Different case definitions used by the hospitals applied to a fixed data set resulted in a 30% difference in rates. No associations were identified between diagnostic test or case definition used and the relative rate of CDAD at a specific medical center.

Conclusions:

Rates of CDAD vary widely at tertiary-care centers across the United States. No significant increases in case rates were identified. The varying clinical and laboratory approaches to diagnosis complicated comparisons between hospitals. To facilitate benchmarking and comparisons between institutions, we recommend development of a more standardized case definition.

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Fekety, R, McFarland, LV, Surawicz, CM, Greenberg, RN, Elmer, GW, Mulligan, ME. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997;24:324333.CrossRefGoogle Scholar
2.McFarland, LV, Elmer, GW, Surawicz, CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002;97:17691775.CrossRefGoogle ScholarPubMed
3.Kyne, L, Hamel, MB, Polavaram, R, Kelly, CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002;34:346353.CrossRefGoogle ScholarPubMed
4.McDonald, L. Epidemiology and burden of Clostridium difficile-associated disease in US acute care hospitals: a case for new efforts in surveillance and control. Presented at the 14th Annual Meeting of the Society for Healthcare Epidemiology of America; April 17-20, 2004; Philadelphia, PA.Google Scholar
5.McDonald, L. Increasing incidence of Clostridium difficile-associated disease in US acute care hospitals. Presented at the 14th Annual Meeting of the Society for Healthcare Epidemiology of America; April 17-20, 2004; Philadelphia, PA.Google Scholar
6.Archibald, LK, Banerjee, SN, Jarvis, WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004;189:15851589.CrossRefGoogle ScholarPubMed
7.Kleinbaum, DF, Kupper, LL, Muller, KE. Applied Regression Analysis and Other Multivariable Methods. Boston: PWS-KENT; 1988.Google Scholar
8.Kaplan, JE, Gase, K, Eagan, JA, Sepkowitz, KA, Sohn, S. Case definition has a substantial impact on nosocomial Clostridium difficile rates. Presented at the 14th Annual Meeting of the Society for Healthcare Epidemiology of America; April 17-20, 2004; Philadelphia, PA. Abstract 04-A-437.Google Scholar
9.Gerding, DN, Johnson, S, Peterson, LR, Mulligan, LE, Silva, J Jr.Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459477.CrossRefGoogle ScholarPubMed
10.Fekety, R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am J Gastroenterol 1997;92:739750.Google ScholarPubMed
11.Simor, AE, Bradley, SF, Strausbaugh, IJ, Crossley, K, Nicolle, LE, SHEA Long-Term-Care Committee. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol 2002;23:696703.CrossRefGoogle ScholarPubMed